Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: celeryroot.com who wrote (24409)	8/12/1998 12:04:00 PM
From: Henry Niman	Respond to of 32384

Celeryroot, I threw Farallon in as a potential seller, because they like to do arbitrage, not invest in Biotechs. At these low prices, I think that big block selling is much more likely to be by AGN. I see AGN as wanting to unload the stock of their competitor and having a plan to sell X amount each quarter. Farallon is looking to make as much as possible on their arbitrage position, which I think that will eventually unwind, but not at these very low prices.